Market Access : : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / / Giuseppe Galliverti, Nicola Saraceni and Federico Lega.

If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect st...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
TeilnehmendeR:
Place / Publishing House:Milan, Italy : : Milano University Press,, 2023.
Year of Publication:2023
Language:Italian
Physical Description:1 online resource (164 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993599263004498
ctrlnum (CKB)4960000000467607
(NjHacI)994960000000467607
(EXLCZ)994960000000467607
collection bib_alma
record_format marc
spelling Galliverti, Giuseppe, author.
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega.
Market Access. Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science
Milan, Italy : Milano University Press, 2023.
1 online resource (164 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect storm, it has become a reality at least since the early years of the new century. The world in which access to the market, the introduction of innovation, and consolidation of sales were built around the supervision of regulatory processes and the share of voice towards the prescribers have become much more complex. A context that many define as VUCA (volatile, uncertain, complex, ambiguous). In this book, therefore, both the reasons that prompted Life Science companies to rethink their strategy by dedicating increasing attention to the political and institutional decision-makers of the Regions and the management of healthcare companies, and the internal organization to support and strengthen their "market access" capabilities. Through the different perspectives - academic, consultancy, managerial - of the three authors, the logic that has guided the "change of skin" of Life Science companies is explored, as the functional tools for market access, the different declinations that this activity has had in the sector, future scenarios and further evolutionary prospects, the connection with the other company functions - sales, marketing, medical management, institutional affairs, administration - and many technical aspects which are the heart of the skills and toolbox required of those who want to successfully develop a career right in the field of market access.
Life sciences.
Management.
979-1-255-10022-5
Lega, Federico, author.
Saraceni, Nicola, author.
language Italian
format eBook
author Galliverti, Giuseppe,
Lega, Federico,
Saraceni, Nicola,
spellingShingle Galliverti, Giuseppe,
Lega, Federico,
Saraceni, Nicola,
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /
author_facet Galliverti, Giuseppe,
Lega, Federico,
Saraceni, Nicola,
Lega, Federico,
Saraceni, Nicola,
author_variant g g gg
f l fl
n s ns
author_role VerfasserIn
VerfasserIn
VerfasserIn
author2 Lega, Federico,
Saraceni, Nicola,
author2_role TeilnehmendeR
TeilnehmendeR
author_sort Galliverti, Giuseppe,
title Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /
title_sub Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /
title_full Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega.
title_fullStr Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega.
title_full_unstemmed Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega.
title_auth Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /
title_alt Market Access. Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science
title_new Market Access :
title_sort market access : nuovi paradigmi manageriali e strumenti operativi per le imprese del life science (perché niente è più come prima) /
publisher Milano University Press,
publishDate 2023
physical 1 online resource (164 pages)
isbn 979-1-255-10022-5
callnumber-first H - Social Science
callnumber-subject HD - Industries, Land Use, Labor
callnumber-label HD31
callnumber-sort HD 231 G355 42023
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 650 - Management & public relations
dewey-ones 658 - General management
dewey-full 658
dewey-sort 3658
dewey-raw 658
dewey-search 658
work_keys_str_mv AT gallivertigiuseppe marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescienceperchenienteepiucomeprima
AT legafederico marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescienceperchenienteepiucomeprima
AT saraceninicola marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescienceperchenienteepiucomeprima
AT gallivertigiuseppe marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescience
AT legafederico marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescience
AT saraceninicola marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescience
status_str n
ids_txt_mv (CKB)4960000000467607
(NjHacI)994960000000467607
(EXLCZ)994960000000467607
carrierType_str_mv cr
is_hierarchy_title Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796653152439631872
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02916nam a2200337 i 4500</leader><controlfield tag="001">993599263004498</controlfield><controlfield tag="005">20230630064726.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230630s2023 it o 000 0 ita d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4960000000467607</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994960000000467607</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994960000000467607</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="1" ind2=" "><subfield code="a">ita</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HD31</subfield><subfield code="b">.G355 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">658</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Galliverti, Giuseppe,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Market Access :</subfield><subfield code="b">Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /</subfield><subfield code="c">Giuseppe Galliverti, Nicola Saraceni and Federico Lega.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Market Access. Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Milan, Italy :</subfield><subfield code="b">Milano University Press,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (164 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect storm, it has become a reality at least since the early years of the new century. The world in which access to the market, the introduction of innovation, and consolidation of sales were built around the supervision of regulatory processes and the share of voice towards the prescribers have become much more complex. A context that many define as VUCA (volatile, uncertain, complex, ambiguous). In this book, therefore, both the reasons that prompted Life Science companies to rethink their strategy by dedicating increasing attention to the political and institutional decision-makers of the Regions and the management of healthcare companies, and the internal organization to support and strengthen their "market access" capabilities. Through the different perspectives - academic, consultancy, managerial - of the three authors, the logic that has guided the "change of skin" of Life Science companies is explored, as the functional tools for market access, the different declinations that this activity has had in the sector, future scenarios and further evolutionary prospects, the connection with the other company functions - sales, marketing, medical management, institutional affairs, administration - and many technical aspects which are the heart of the skills and toolbox required of those who want to successfully develop a career right in the field of market access.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Life sciences.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Management.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">979-1-255-10022-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lega, Federico,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saraceni, Nicola,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:04:25 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-05-13 19:27:32 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5345558210004498&amp;Force_direct=true</subfield><subfield code="Z">5345558210004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345558210004498</subfield></datafield></record></collection>